Trial Profile
Erwinia L-Asparaginase (Erwinase) Study in Patients With Acute Lymphoblastic Leukemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2014
Price :
$35
*
At a glance
- Drugs Crisantaspase (Primary) ; Crisantaspase (Primary) ; Crisantaspase (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 18 Apr 2012 Actual patient number (33) added as reported by ClinicalTrials.gov.
- 16 Feb 2012 Actual patient number (33) added as reported by ClinicalTrials.gov.
- 16 Feb 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.